In contrast, interferon-γ promotes the formation of an antifibrotic immune microenvironment in the lung by, among other things, inhibiting TGF-β activity, thereby alleviating the progression of pulmonary fibrosis [14, 15]. Here, TGFB1 is linked to pulmonary fibrosis.